Trip.com (TCOM) Now Trades Above Golden Cross: Time to Buy? — Positive
TCOM Zacks Investment Research — September 10, 2025After reaching an important support level, Trip.com Group Limited Sponsored ADR (TCOM) could be a good stock pick from a technical perspective. TCOM recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
Wall Street Analysts Think Great Lakes Dredge & Dock (GLDD) Could Surge 27.23%: Read This Before Placing a Bet — Positive
GLDD Zacks Investment Research — September 10, 2025The consensus price target hints at a 27.2% upside potential for Great Lakes Dredge & Dock (GLDD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Roots Corporation (ROOT:CA) Q2 2025 Earnings Call Transcript — Neutral
ROOT RROTF Seeking Alpha — September 10, 2025Roots Corporation (TSX:ROOT:CA ) Q2 2025 Earnings Call September 10, 2025 8:00 AM EDT Company Participants Meghan Roach - President, CEO & Director Leon Wu - Chief Financial Officer Conference Call Participants Brian Morrison - TD Cowen, Research Division Presentation Operator Good morning. My name is Elliot, and I will be your conference operator today.
Amazon kicks off Zoox robotaxi service in Las Vegas — Positive
AMZN Proactive Investors — September 10, 2025Amazon.com Inc (NASDAQ:AMZN) on Wednesday launched its Zoox robotaxi service in Las Vegas, offering free rides to passengers from a few locations. The company said it has spent two years testing the vehicle in the city.
Ozempic Parent Announces 9,000 Job Cuts in Restructuring Plan — Negative
NVO Schaeffers Research — September 10, 2025Pharmaceutical name Novo Nordisk A/S (NYSE:NVO), the maker of weight-loss drugs Wegovy and Ozempic, is in the spotlight today after announcing roughly 9,000 job cuts and slashing its full-year guidance.
Synopsys: Selloff Brings Shares Down, But Not Down Enough — Negative
SNPS Seeking Alpha — September 10, 2025I maintain a Hold rating on Synopsys, Inc. due to high valuation, increased debt, and thin free cash flow yield despite the recent selloff. While demand for design automation remains strong and the Ansys acquisition adds potential, risks from China and chip foundry exposure persist. The company's IP business struggled this quarter, but management is restructuring and focusing on higher-value, longer-term IP contracts.
GitLab: Conviction In Growth Acceleration Has Gone Up — Positive
GTLB Seeking Alpha — September 10, 2025GitLab's 2Q26 results showed re-accelerating revenue growth, expanding margins, and strong cash flow, confirming my bullish thesis and easing investor concerns. AI is a tailwind, not a threat—paid seat growth remains robust, and customer surveys indicate AI will increase platform usage and developer headcount. Enterprise momentum is strong, with Ultimate tier adoption rising and GitLab Dedicated ARR surging, highlighting GTLB's deepening enterprise relationships.
LNTH LAWSUIT: Lantheus Holdings Inc. Sued For Securities Fraud; Investors Should Contact Block & Leviton to Potentially Recover Losses — Neutral
LNTH GlobeNewsWire — September 10, 2025Block & Leviton announces that a securities fraud lawsuit has been filed against Lantheus Holdings Inc. (Nasdaq: LNTH). Investors should contactthe firm.
Larry Ellison Nearly $100 Billion Richer As Oracle Surges In Largest Rally Since 1992 — Positive
ORCL Forbes — September 10, 2025Ellison, who holds a roughly 41% stake in the company, ranks the second-wealthiest person in the world with a fortune estimated at $391.8 billion. His equity in Oracle rose from $279.7 billion as of Tuesday's closing price to about $377 billion on Wednesday.
Oracle's Exceptional Outlook Boosts Stock to Record Highs — Positive
ORCL Schaeffers Research — September 10, 2025Shares of Oracle Corp (NYSE:ORCL) are up an impressive 35% to trade at $325.95, after the tech company announced that it expects its AI-powered cloud infrastructure revenue to jump from $10.3 billion in 2025 to $144 billion in 2030.
Here's Why Array Technologies, Inc. (ARRY) is a Strong Momentum Stock — Positive
ARRY Zacks Investment Research — September 10, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Capital One (COF) is a Strong Momentum Stock — Positive
COF Zacks Investment Research — September 10, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Evercore (EVR) is a Top Momentum Stock for the Long-Term — Positive
EVR Zacks Investment Research — September 10, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why AutoNation (AN) is a Strong Momentum Stock — Positive
AN Zacks Investment Research — September 10, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Imax (IMAX) is a Top Momentum Stock for the Long-Term — Positive
IMAX Zacks Investment Research — September 10, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Stanley Black & Decker (SWK) is a Strong Momentum Stock — Positive
SWK Zacks Investment Research — September 10, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why GitLab Inc. (GTLB) is a Top Momentum Stock for the Long-Term — Positive
GTLB Zacks Investment Research — September 10, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cullinan Therapeutics, Inc. (CGEM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript — Neutral
CGEM Seeking Alpha — September 10, 2025Cullinan Therapeutics, Inc. (NASDAQ:CGEM ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 8:30 AM EDT Company Participants Chad Messer Nadim Ahmed - President, CEO & Director Jeffrey Jones - Chief Medical Officer Conference Call Participants Sean Laaman - Morgan Stanley, Research Division Presentation Sean Laaman Head of Healthcare Research & Equity Analyst Good morning, everyone, and welcome to Morgan Stanley's Global Healthcare Conference. I'm Sean Laaman, Head of U.S. Smid-Cap Biotech Equity Research here at the firm.
Pearson steadies nerves with enrolment hopes — Positive
PSO Proactive Investors — September 10, 2025Pearson PLC (LSE:PSON) shares have been stuck in the doldrums, but UBS thinks the education group may be due a lift. Its analysts reckon student enrolments in the United States this autumn could surprise on the upside, offering reassurance on a business often seen as hostage to college numbers.
BanColombia S.A. (CIB) Hits Fresh High: Is There Still Room to Run? — Positive
CIB Zacks Investment Research — September 10, 2025Bancolombia (CIB) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
